BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 38698698)

  • 21. Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancer.
    Derksen JWG; Smit KC; May AM; Punt CJA
    Eur J Cancer; 2022 May; 166():73-86. PubMed ID: 35279472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-1 for the treatment of gastrointestinal cancer.
    Satoh T; Sakata Y
    Expert Opin Pharmacother; 2012 Sep; 13(13):1943-59. PubMed ID: 22860709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral fluoropyrimidine treatment of colorectal cancer.
    Eng C; Kindler HL; Schilsky RL
    Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone.
    Glimelius B; Stintzing S; Marshall J; Yoshino T; de Gramont A
    Cancer Treat Rev; 2021 Jul; 98():102218. PubMed ID: 34015686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison.
    Saif MW
    Clin Colorectal Cancer; 2005 Jul; 5(2):89-100. PubMed ID: 16098249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history.
    Kelly C; Bhuva N; Harrison M; Buckley A; Saunders M
    Eur J Cancer; 2013 Jul; 49(10):2303-10. PubMed ID: 23583220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
    Kinos S; Hagman H; Halonen P; Soveri LM; O'Reilly M; Pfeiffer P; Frödin JE; Sorbye H; Heervä E; Liposits G; Kallio R; Ålgars A; Ristamäki R; Salminen T; Bärlund M; Shah CH; McDermott R; Röckert R; Flygare P; Kwakman J; Teske A; Punt C; Glimelius B; Österlund P
    Acta Oncol; 2024 May; 63():248-258. PubMed ID: 38698698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fluoropyrimidines cardiac toxicity: 5-fluorouracil, capecitabine, compound S-1 and trifluridine/tipiracil].
    Vaflard P; Ederhy S; Torregrosa C; André T; Cohen R; Lopez-Trabada D
    Bull Cancer; 2018; 105(7-8):707-719. PubMed ID: 29960638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capecitabine Versus Continuous Infusion Fluorouracil for the Treatment of Advanced or Metastatic Colorectal Cancer: a Meta-analysis.
    Wu Z; Deng Y
    Curr Treat Options Oncol; 2018 Nov; 19(12):77. PubMed ID: 30483908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [S-1 as a single agent for colorectal cancer].
    Eguchi T; Shirao K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():121-4. PubMed ID: 16897986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.